The evaluation of Remdesivir Utilization pattern and its correlation with clinical indicators in hospitalized patients during COVID
Background: In 2019 COVID became the cause of a pandemic, with approximately 500,000 deaths in six months worldwide. Remdesivir, the first drug approved by the U.S. Food and Drug Administration (FDA) for COVID-19 treatment, gained attention from numerous medical centers worldwide. Objective:The cons...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Knjiga |
| Izdano: |
Research Center for Rational Use of Drugs (RCRUD),
2023-12-01T00:00:00Z.
|
| Teme: | |
| Online dostop: | Connect to this object online. |
| Oznake: |
Označite
Brez oznak, prvi označite!
|
Internet
Connect to this object online.3rd Floor Main Library
| Signatura: |
A1234.567 |
|---|---|
| Kopija 1 | Prosto |